A multi-centre Phase IIa double-blind, placebo-controlled study to investigate the efficacy and safety of GSK3196165 in subjects with inflammatory hand osteoarthritis.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2017
At a glance
- Drugs GSK 3196165 (Primary)
- Indications Osteoarthritis; Pain
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 21 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2017 Planned End Date changed from 9 Nov 2017 to 6 Dec 2017.
- 08 Jun 2017 Planned primary completion date changed from 9 Nov 2017 to 6 Dec 2017.